Moneta Group Investment Advisors’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-19,496
| Closed | -$32.4K | – | 608 |
|
|
2023
Q4 | $32.4K | Hold |
19,496
| – | – | ﹤0.01% | 558 |
|
|
2023
Q3 | $17.5K | Hold |
19,496
| – | – | ﹤0.01% | 522 |
|
|
2023
Q2 | $41.9K | Hold |
19,496
| – | – | ﹤0.01% | 534 |
|
|
2023
Q1 | $38K | Hold |
19,496
| – | – | ﹤0.01% | 528 |
|
|
2022
Q4 | $74.9K | Sell |
19,496
-6
| -0% | -$23 | ﹤0.01% | 442 |
|
|
2022
Q3 | $94K | Buy |
19,502
+5
| +0% | +$24 | ﹤0.01% | 415 |
|
|
2022
Q2 | $155K | Buy |
19,497
+28
| +0.1% | +$223 | 0.01% | 445 |
|
|
2022
Q1 | $286K | Sell |
19,469
-36
| -0.2% | -$529 | 0.01% | 366 |
|
|
2021
Q4 | $394K | Sell |
19,505
-9
| -0% | -$182 | 0.02% | 333 |
|
|
2021
Q3 | $530K | Buy |
19,514
+7
| +0% | +$190 | 0.02% | 271 |
|
|
2021
Q2 | $475K | Buy |
19,507
+7
| +0% | +$170 | 0.02% | 290 |
|
|
2021
Q1 | $476K | Buy |
+19,500
| New | +$476K | 0.03% | 267 |
|